Table 1.
Year | Microorganism | Antibiotic | In Vivo | Human Infection | Observation | Reference |
---|---|---|---|---|---|---|
1941 | Staphyloccoci | Sulphanilamide Sulphapyridine Sulphathiazole |
No | No | Synergistic | [10] |
1941 |
S. aureus
E. coli |
Sulphanilamide Sulphapyridine |
No | No | Synergistic | [9] |
1942 | Staphylococci | Sulphathiazole | Rabbit | No | Synergistic | [11] |
1943 | Staphylococci | Neo-arsphenamine Sulphanilamide |
/ | Various types of infection | Synergistic | [12] |
1943 | Staphylococci | Neo-arsphenamine Sulphanilamide |
/ | Neurological infections | Synergistic | [13] |
1945 | Staphylococci | Penicillin | No | No | Synergistic | [14] |
1945 | E. coli | Streptothricin Streptomycin Clavacin |
No | No | Antagonistic | [18] |
1945 | Staphyloccoci | Penicillin | / | Cardiac infections | Synergistic | [15] |
1945 |
Staphyloccoci
Streptococci |
Penicillin | / | Cardiac infections | Synergistic | [16] |
1946 |
Staphyloccoci
Streptococci E. coli |
Penicillin | / | Various types of infection | Synergistic | [17] |
1949 1950 |
S. aureus
E. coli |
Streptomycin Chloromycetin Aureomycitin Terramycin |
No | No | Antagonistic | [19,20,21,22,23,24,25] |
1951 | Several bacteria | Quinones Clavacin Subtilin Penicillic acid Ploymixin B Streptomycin |
No | No | Antagonistic | [26] |
1954 | S. aureus | Aureomycin Oxytetracyclin Chloramphenicol |
No | No | Antagonistic | [27] |
1965 | Dysenteric bacilli | Chloramphenicol Tetracycline |
/ | Digestive colonisation | Synergistic | [28] |
1971 | Enterobacteriae Staphylococci |
Not specified | No | No | Synergistic | [29] |
1977 | E. coli | Rifampicin | No | No | Antagonistic | [30] |
2006 | P. aeruginosa | β-Lactam Chloramphenicol Gentamycin |
Mice | No | Synergistic | [31] |
2007 | E. coli | Β-Lactam Quinolone |
No | No | Synergistic | [32] |
2008 | P. aeruginosa | Β-Lactam Quinolone Aminoglycosids |
No | No | Synergistic | [33] |
2008 | Salmonella enterica | Gentamicin Ciprofloxacin |
No | No | Synergistic | [34] |
2009 | K. pneumoniae | Amoxicillin | No | No | Synergistic | [35] |
2011 | S. aureus | Rifampicin | No | No | Synergistic | [36] |
2012 | S. aureus | Gentamycin | No | No | Synergistic | [37] |
2012 | E. coli | Cefotaxime | No | No | Synergistic | [38] |
2013 | S. aureus | Linezolid | No | No | Synergistic | [39] |
2013 | P. aeruginosa | Ceftriaxone | No | No | Synergistic | [40] |
2013 |
S. aureus
P. aeruginosa |
Teicoplanin Imipenem Amikacin |
Rat | No | Synergistic | [41] |
2014 | Mycobacterium smegmatis | Ethambutol | No | No | Synergistic | [42] |
2014 |
E. coli
P. aeruginosa |
Tobramycin | No | No | Synergistic | [43] |
2014 | S. aureus | Linezolid | No | No | Synergistic | [44] |
2014 | P. aeruginosa | Streptomycin | No | No | Synergistic | [45] |
2015 | S. aureus | Gentamycin Vancomycin Tetracyclin |
No | No | Synergistic | [46] |
2015 | Burkholderia cepacia | Ciprofloxacin Meropenem Tetracycline Minocycline Levofloxacin Ceftazidime |
No | No | Synergistic | [47] |
2016 | S. aureus | Linezolid | Mice | No | Synergistic | [48] |
2017 | P. aeruginosa | Ceftazidime Ciprofloxacin Tobramycin |
No | No | Synergistic | [49] |
2018 | P. aeruginosa | Ciprofloxacin Tobramycin Colistin Aztreonam Amikacin |
No | No | Synergistic | [50] |
2018 | P. aeruginosa | Piperacillin Ceftazidime |
No | No | Synergistic | [51] |
2019 |
P. aeruginosa
S. aureus |
Aminoglycosid Tetracycline Chloramphenicol Meropenem Erythromycin Ciprofloxacin |
No | No | Synergistic | [52] |
2019 | Enterococci | Vancomycin | No | No | Synergistic | [53] |
2020 | S. aureus | Dalbavancin | / | Neurological infection | Synergistic | [54] |
2020 | S. aureus | Daptomycin | / | Osteoarticular infection | Clinical failure | [55] |
2020 | Achromobacter spp. | Cefiderocol Meropenem-varobactam |
/ | Pulmonary infection | Synergistic | [56] |
2020 | Acinetobacter baumanii | Ciprofloxacin Meropenem |
No | No | Synergistic | [57] |
2020 | Enterococcus faecium | Daptomycin | No | No | Synergistic | [58] |
2020 | Serratia marcescens | Ampicillin- Sulbactam |
No | No | Synergistic | [59] |
2021 |
E. coli
Bacillus cereus |
Aminoglycosids | No | No | Antagonistic | [60] |
2021 | E. coli | β-lactams Fluoroquinolones Colistin sulphate Trimethoprim-sulphamethoxazole Tetracyclines Amino-glycosides |
No | No | Synergistic Possibly antagonistic |
[61] |
2022 | E. coli | Ciprofloxacin Rifampicin | No | No | Synergistic | [62] |